Stoke Therapeutics (STOK) Other Operating Expenses (2019 - 2025)
Stoke Therapeutics (STOK) recorded quarterly Other Operating Expenses of -$218.7 million in Q4 2025, down 386.75% quarter-over-quarter from -$44.9 million in Q2 2025, and down 297.25% on a YoY basis from $110.9 million in Q4 2024.
Stoke Therapeutics (STOK) Other Operating Expenses (2019 - 2025) Analysis & Trends
Stoke Therapeutics' Other Operating Expenses history runs 3 years deep, the most recent figure standing at -$218.7 million for Q4 2025.
- In Q4 2025, Other Operating Expenses fell 297.25% year-over-year to -$218.7 million; the TTM figure through Mar 2026 stood at -$263.6 million (down 460.87% YoY), while the FY2025 annual figure was -$218.7 million, changed N/A from the prior year.
- Other Operating Expenses was -$218.7 million for Q4 2025 at Stoke Therapeutics, down from -$44.9 million in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $110.9 million in Q4 2024 to a low of -$218.7 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Stoke Therapeutics | 1.95 Bn | 1.95 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -218.72 Mn |
| Jun 30, 2025 | -44.93 Mn |
| Dec 31, 2024 | 110.88 Mn |
| Jun 30, 2024 | -37.82 Mn |
| Mar 31, 2024 | -34.59 Mn |
| Dec 31, 2019 | 1,000.00 |